MERIDIAN BIOSCIENCE $22.01

up +0.31


17/5/2013 04:17 PM  |  NASDAQ : VIVO  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 13% - VIVO has underperformed the S&P 500 by 13%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Meridian Bioscience Inc. Reports Operating Results (10-Q)

    GuruFocus
  2. Meridian Subsidiary Bioline, Launches ISOLATE II

    Benzinga
  3. 20 Best Yielding Healthcare Growth Stocks and Which to Buy

    GuruFocus
  4. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The ...

    Benzinga
  5. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The ...

    Benzinga
  6. Top 4 Stocks In The Diagnostic Substances Industry With The ...

    Benzinga
  7. Meridian Bioscience, Inc. (VIVO) Exec VP, CFO Melissa Lueke sells ...

    GuruFocus
  8. Meridian Bioscience, Inc. (VIVO) Executive Chairman William J ...

    GuruFocus
  9. UPDATE: Wedbush Securities Downgrades Meridian Bioscience to ...

    Benzinga
  10. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With ...

    Benzinga
  11. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With ...

    Benzinga
  12. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The ...

    Benzinga
  13. 16 Best Dividend Paying Healthcare Stocks

    GuruFocus
  14. Health Care Sector Wrap

    FOXBusiness
  15. 15 of the Best Growing Dividend Achievers

    GuruFocus
  16. Health Care Sector Wrap

    FOXBusiness
  17. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With ...

    Benzinga
  18. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With ...

    Benzinga
  19. Meridian Bioscience Receives FDA Clearance for New Legionella Test

    at Benzinga
  20. Top 4 Stocks In The Diagnostic Substances Industry With The ...

    at Benzinga
  21. Meridian Bioscience Inc. Reports Operating Results (10-Q)

    at GuruFocus
  22. The Best Yielding Healthcare Dividend Stocks with Fastest Earnings ...

    at GuruFocus
  23. UPDATE: Wedbush Downgrades Meridian Bioscience to Underperform

    at Benzinga
  24. Meridian Bioscience Inc. (VIVO) Executive Chairman William J Motto ...

    at GuruFocus
  25. 10 High Margin Healthcare Dividend Shares

    at GuruFocus
  26. Meridian Bioscience Receives FDA Clearance For ImmunoCard C. ...

    at Benzinga
  27. Meridian Bioscience Receives FDA Clearance for New Molecular Test: ...

    at Benzinga
People viewing VIVO also viewed: , , , , , ,
Marketplace
Trading Center